vtlv للمتابعه

الشاملى

عضو جديد
التسجيل
1 سبتمبر 2001
المشاركات
2
الإقامة
طرابلس - الجماهيرية
السلام عليكم ورحمة الله وبركاته
لقد شدني سهم
يستحق المجازفة بمبلغ فائض عن الحاجة على ألا بتضرر المستثمر من فقدانه .

أن ارتفع سعره عوائد غير متوقعة .

رمز الشركة المالكة فئ نسديك Skyepharma PLC (SKYE)
رمز الشركة المالكة فى لندن Skyepharma PLC (SKP.L)


الميزانية والدخل بصورة أوضح حتى سبتمبر 2004
http://www.marketwatch.com/tools/quotes/financials.asp?symb=VTLV&sid=1038306&report=2&freq=1


سوف أحاول دراستها أن اسعفنى الوقت .

بتوفيق إنشاء الله
 

m&m

عضو محترف
التسجيل
27 أغسطس 2002
المشاركات
2,086
الإقامة
السعوديه
هلا وغلا با أهل طرابلس :)

ونتظر ابداعاتك

شكرا جزيلا يالشاملي
 

الشاملى

عضو جديد
التسجيل
1 سبتمبر 2001
المشاركات
2
الإقامة
طرابلس - الجماهيرية
السلام عليكم ورحمة الله وبركاته
كانت قد قد بداءت فى دراسة الشركة فدهشنى طريقة الشركة في الحصول على براءات المنتجات والتي تشكل اغلب إجمالي الأصول ومصادر تمويلها ، وكان الاعتقاد لدي في البداية بان اكبر مساهم SkyePharma, PLC) ) يحقق وفرات ضريبية على اعتبار إن قيمة رأس المال المستثمر لا يمثل شي مقارنة مع الخسائر المحققة ففوجئت بان الشركة الأم هي أيضا في مرحلة خسائر .
وعند بداية دراستي للنتائج الشركة عن الربع الثالث لسنة 2004 فوجئت بان العلاقة التعاقدية بين شركتين قد لأتكون على مايرام وذلك ناتج عند عدم الالتزام شركة بالاتفاقية التي إلا إليها بموجبها براءات اختراع من شركة SkyePharma, PLC وان الوضع قد يصل الى مراحل التقاضي وانه يتوجب دفع مليون دولار سنويا للشركة SkyePharma يستحق منها حتى نهاية ستمبر مبلغ 750 الف دولار وانه وردت مطالبات بسداد المبلغ

هذه البيانات مستقاة من تقرير 30 سبتمبر 2004

6. COMMITMENTS AND CONTINGENCIES

From time to time, the Company is party to a variety of legal proceedings arising out of the normal course of business, including cases in which damages may be sought. The Company believes it has valid defenses and is vigorously defending any pending litigation. While the results of litigation cannot be predicted with certainty, the Company believes that the outcome of any proceedings will not have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

In connection with the ENI acquisition, the Company became party to a Development and License Agreement, as amended, (collectively, the "ENI Agreements") with SkyePharma, PLC ("Skye"). Under the terms of the Development and License Agreement, as amended, with Skye, the Company has the right through December 31, 2017, or until such later date that the patents relating to Skye's patented drug-delivery technology, GEOMATRIX, expires, to identify dietary products and nutriceutical and functional supplements for Skye to develop using GEOMATRIX technology. The Company is entitled to market and license such products to other parties and is obligated to pay Skye $1,000,000 of development fees per year and certain royalties on all sales of such products. In addition, the Company was appointed as Skye's exclusive marketing partner to pharmaceutical companies for licensing of all Skye technology (including GEOMATRIX technology) relating to the delivery of drugs and other vitamins in China, Taiwan or Hong Kong. Skye agreed to pay the Company a royalty on all gross revenues received by Skye as a result of these marketing rights.

Should the Company fail to meet its commitments under the ENI Agreements, product selection and license exclusivity rights will terminate at the end of the respective calendar year without effect on rights attained in prior years.

The Company is currently in dispute with Skye over the terms of the ENI Agreements and has failed to cure three of four delinquent payments to Skye of $250,000 each due at the beginning of each quarter of 2004. On April 6, 2004, the Company received a demand letter from Skye related to the January 2004 and April 2004 past due payments, one of which was subsequently paid in June 2004, which triggered the 30 day negotiation period under the agreement, as required before initiating formal collection proceedings. As of November 6, 2004, the Company is $750,000 in arrears. The Company is currently in discussions to modify both the terms and payment schedules under the ENI Agreements. While Management believes that it will reach a successful settlement to the terms and conditions there under, no assurance can be given that these


negotiations will be successful or that the Company will reach a satisfactory resolution of this matter. In the event a satisfactory resolution cannot be reached and Skye exercises its rights of termination under the ENI Agreements, the Company could lose substantial, or possibly all, rights under the ENI Agreements. Accordingly, amounts recorded as intangible assets associated with these contracts, which represent substantially all of the Company's intangible assets, would be impaired. However, until Skye exercises its termination rights under the ENI Agreements, the Company's rights under the agreements are deemed to be in full force and effect and the related intangibles unimpaired.
During March and April 2004, the Company entered into Purchase Agreements and sold 510,000 shares of the Company's common stock at $1.00 per share with rights to receive a portion of the Company's net revenues, as defined therein, from the sale of X-Fat(R) ("the Royalty Rights"). Under the terms of the agreements, finder's fees are paid to certain individuals as compensation equal to cash of 8% of funds raised and shares of the Company's common stock equal to 8% of the number of shares issued under the agreement. Investors shall receive Royalty Rights on a pro-rata basis of 10% and 3% on the first $15,000,000 and subsequent $85,000,000 of X-Fat(R) net revenues, respectively, during the two-year period commencing April 1, 2004 and terminating March 31, 2006. Royalty payments on the first $15,000,000 and subsequent $85,000,000 of net revenues shall be made in cash and shares of common stock valued at $1.00 per share, respectively. Cash payments must be made within 50 days after the end of each calendar quarter and within 105 days after the end of each year. As of November 6, 2004, no material gross sales subject to the agreements had occurred.

عليه أرى أن تتطلع على تقرير المذكور حتى تكون على علم بكل مجريات الامور وخصوص الاتفاقيات المبرمة

والسلام عليكم ورحمة الله وبركاته
 

m&m

عضو محترف
التسجيل
27 أغسطس 2002
المشاركات
2,086
الإقامة
السعوديه
جزاكم الله خير

اخي الكريم على معلوماتك

EPS (ttm): -0.39 الارباح لكل سهم بالسالب

في حالة الشركة الصغيره هذه استطاعت الحصول على بوسيتف كاش فلو !!


positive cash flow

وبعد أن اكتساب مشروع مشترك شريك
a joint venture partner

http://biz.yahoo.com/bw/050222/225995_1.html
http://biz.yahoo.com/bw/050307/75122_1.html
وموجود في اخر الاخبار
وهو الحظ الذي ابحث عنه
اعلم يقين ان تلك الشركة كا غيرها مخاطره والان انتظر هذا الحظ pcf
الشركة تقدم خطوه وتتاخر خطوتين !

ربما اكون على صواب وربما اكون على خطأ
ولكن توخذ الدنيا غلابا :)


شكرا اخي الشاملي وزد علينا من معلوماتك اخي بارك الله فيكم

سوف ابيعها بالنظر في تقاريره القادمة( لكن عندي احساس داخلي يقول لي لا تبيع السهم بيروح لا اعلا ,,, والله اعلم) صدق لا امزح

والتوفيق بيد الله
 

m&m

عضو محترف
التسجيل
27 أغسطس 2002
المشاركات
2,086
الإقامة
السعوديه
بسم الله وعلى الكريم توكلت

امر هالشركة يحير

والله صرت ما انام الا الحاسبه معي

احسب كم ارباحي :eek:

على العموم الشركتين لهما اتفاقيه

ولكن السكاي فارما مولتها تقريبا 60 مليون من ذاكرتي
ولابد فتلف ترد المبلغ وفوقه حبة خشم

على العموم السوق بالنسبة لشركتي جيد



والبضاعة والمتجات جيده

نحسبها
:)
2000 متجر كل يوم يدخل واحد !! ويشتري xfat
سعره 79 دولار
لكن نحسب التكلفه وهو 30 دولار اقل تقدير

شهريا يعني 30 شخص

2000*1*30*30=1.8مليون
طري 3 اشهر=5.4 مليون
ضرب4 مرات=21 مليون

5 اشخاص
108 مليون
فرضا نفر بده يخفف وزنه او بمعنى كل ما تشتهي ما تريد لديك تكنولوجيا xfat منع امتصاص الدهون وتكون الشحوم

ونفس الحسبه على 3 منتجات الباقيه

مثل ماقلت الفلو كاش تجيبه لو اراد الله
ولا تحتاج لسكايفارما بعد اذا
غير الاتفاقيات للصين
وخطوط انتاج اخرى

المهم ما اطول عليكم وانا اثق بالله اولا واخيرا
واللله كريم
بخسارة او ربح

ماقلت لكم لازم نقطع تذكره لامريكا وندور على المتاجر هناك

والله حاله :)
 

m&m

عضو محترف
التسجيل
27 أغسطس 2002
المشاركات
2,086
الإقامة
السعوديه
السهم للمتابعه

وبني ستوك الآن

وعندي امل وثقه بالله

يتحسن

الاست 0999.سنت

ماشاء الله عليهم تقريبا 10. سنت
 

زارع الامل

عضو نشط
التسجيل
19 يناير 2004
المشاركات
688
الإقامة
الكويت
الله يربحك بهالسهم بس عندي استفسار ولا عليك امر شنو يخليك تتفائل بهالسهم انا شايف هالسهم ثقيل معلش يا ام اند ام خذني علي نظرتي لحركه السهم :d
 

m&m

عضو محترف
التسجيل
27 أغسطس 2002
المشاركات
2,086
الإقامة
السعوديه
هلا اخوي مشكور على الدعوة لكم بالمثل والله افرحتني دعوتك لي بارك الله فيك
ملاحظتك جيده ..
السهم جيد من وجهة نظري.. مبدائيا السهم هلكته ردود وثانيا ننتظر اسعار اعلا من هذه الثقيله على قولتك
واهدافي 30 سنت الى ما شاء الله نقول ان شاء الله
والاسهم هذه ليست بافضل من اسهم الشيوخ.. ولكن انا ابحث عن الحظ (قبلها ارادة الله سبحانه وتعالى ) اذ لم انجح فهدذا قدري وقدر السهم

اذا شركه ما لها
منتج او المنتجات في خط الانتاج ( كامنتجات الطاقه مثال hans
http://finance.yahoo.com/q/ks?s=hans
الرسم البياني تصاعدي
لان منتجاتها في توسع (ورغم مضار تلك المشروبات)

اما فتلف صحيه بايو فارماسيوتيكال نحكم هل
عليه اقبال او لا (هذا في علم الغيب لا نعلمه ) بالنسبه للسهم فتلف
متوقع ربعيا تعطي 2 مليون وسنويا 12 ملايين
كم يكون سعرها
هل يكون 10 سنت ؟
بدون ما ندخل في سياسة الشركة وهواشهم ( والمنتجات الاخرى قيد التنفيذ الاسينتيوم لتخفيف الكلسترول وهو صحي متوافق مع fda طبعا لازالت تحت الاختبار وان اشك ان لازال تحت المساومة!!
طبعا كثير من المنتجات التي لا تتفق صحيا مع fda للغرض السابق (تخفيف الكلسترول) الغير جيد مثال كبسولات التوت البري وهي متداوله بكثره في امريكيا
اقرء عنها واعرفون ان السهم سوف يطيرر ويترقى لكن خلال السنه هذه لن يرتفع
العلم عند الله
 

زارع الامل

عضو نشط
التسجيل
19 يناير 2004
المشاركات
688
الإقامة
الكويت
عيل خلني افاول علي هالسهم واحسبه علي الفيبوناتشي يمكن يصدق باذن الله
المحطه الاولي راح يوقف عندها السهم 33 سنت
التوقف الثاني 53 سنت
الثالث 70 سنت
الرابع86 سنت
الخامس 1 ونص هذا علي حسبع الويكلي
علي الديلي اول توقف له هو 11 سنت ونص
13و8 من السنت التوقف الثاني
التوقف الثالث 15 سنت
الرابع 16 سنت
الخامس 20 سنت
:rolleyes:
 

m&m

عضو محترف
التسجيل
27 أغسطس 2002
المشاركات
2,086
الإقامة
السعوديه
:)



ان شاء الله..


تصيب توقعاتك..

ويصيب اهدافك واكثر.. والله أعلم
 

m&m

عضو محترف
التسجيل
27 أغسطس 2002
المشاركات
2,086
الإقامة
السعوديه
طلبت سابقا شهادة تملك باسهم فتلف من البروكر


امس وصلت لي رسالة فيها w8
اعفاء من الضررائب

واسهم فتلف مشيوله من المحفظه

وان شاء الله اضع عليها توقيعي وبالبريد الممتاز


وان شاء الله ترجع للمحفظه وهي معزززه مكرمة :)

والله كريم

وهذه اخر الاخبار
 

abooyaser

عضو محترف - مشرف القسم السعودي
التسجيل
24 مايو 2004
المشاركات
3,425
ليه .....

والمده ... الي متي ....

سلالالالالالالالالالالالالام
 

m&m

عضو محترف
التسجيل
27 أغسطس 2002
المشاركات
2,086
الإقامة
السعوديه
ليه +علشان مايتلاعب فيها البروكر
الان هي في غرفة الحجز المركزي( حجر صحي)

كوارنتي

اما المده علمي علمك يابو ياسر لكن اتوقع اذا وصلت لهم w8 بتكون العمليه سليمه
هذه اول مره تمر علي حقيقه

ننتظر والله يكتب اللي فيه الخير

هذا والله اعلم
 

abooyaser

عضو محترف - مشرف القسم السعودي
التسجيل
24 مايو 2004
المشاركات
3,425
بالتوفيق ان شاء الله

صراحه السهم راكد علي سعر 1. ---
يخوف ....


الله يوفق الجميع ...
سلالالالالالالالام........
 

al7bebe

عضو نشط
التسجيل
24 مارس 2005
المشاركات
10,052
قوه ابو ياسر

الصراحه انا اشتريت هذا السهم يوم كان سعره 0.075 وكثرت الكميه على سعر 0.080 وبعت السهم على 0.13
السهم يرتفع في ارتفاع الفاليوم وينزل في نزول الفاليوم سواء نزل عليه خبر او مانزل.
يعني ممكن تضحي في كميه معينه في شراء السهم بسعر اكثر من سعره اذا كان عندك كميه كبيره في هذا السهم وعند ارتفاعه لوصول هدفك تبيع كل الكميه بربح وتعوض الكميه الصغيره الي اشتريت فيها.
 

m&m

عضو محترف
التسجيل
27 أغسطس 2002
المشاركات
2,086
الإقامة
السعوديه
اخوي ابو ياسر

هذا خبر (نزل يوم الجمعه) 15 فبراير

وهو عن التقرير السنوي او مايسمى10- K لذا ننتظر الربعي الثلاث شهور المنتهية 31 ديسمبر2004
اما الثلاث شهور المنتهيه بتاريخ 30سبتمبر الماضي 2004

Quarter Ended September 30, 2004 Compared to the Quarter Ended September 30, 2003

Revenue: Total revenue for the quarters ended September 30, 2004 and 2003 was $1,061,025 and $40,600 respectively, an increase of $1,020,425. This increase is primarily attributable to our acquisitions of DFN during the fourth quarter of 2003.

30 سبتمبر=المبيعات مليون تقريبا
الرفينيوز للربع الحالي نهايته 31 ديسمبر لم يعلن بل السنوي فقط



http://biz.yahoo.com/e/050415/vtlv.ob10ksb.html
المنتهي بتاريخ 31 ديسمبر (نهاية العام2004)
-------

وللتذكير الرفينيوز للتسع شهور الماضيه
Nine Months Ended September 30
, 2004 Compared to the Nine Months Ended September 30, 2003

Revenue: Total revenue for the nine months ended September 30, 2004 and 2003 was $2,715,876 and $106,747, respectively, an increase of $2,609,129. This increase is primarily attributable to our acquisition of DFN during the fourth quarters of 2003, contributing new revenues during the nine months ended September 30, 2004.


الرفينيوز للسنه : المنتهيه 31 ديسمبر وهو اخر خبر 15 ابريل

Total revenue for the year ended December 31, 2004 was $4.2 million compared with $498,000 for the year ended December 31, 2003, an increase of $3.7 million. This increase was primarily attributable to the growth in our Greensfirst(R) product line, which was acquired as part of the DFN acquisitions in the fourth quarter of 2003

4200000-2,715,876 = مليون ونصف تقريبا (الربع المنتهي بتاريخ31ديسمبر)

السنوات 2003=498,000 الف
2004=4.2 مليون

الربع السابق ( Q3 ) سبتمبر30 للسنه 2004= 1,061,025 بزيادة مقداره
2,513% عن الربع نفس من السنه 2003
والربع الثاني 2004 Q2
253% زيادة عن نفس الفتره 2003
الاهم مقارنة الربع الرابع 2004 مع 2003
طبعا فيه اشيا لم افهمها
لكن ان شاء الله مافيه حرق للكاش
والكاش فلو بوسيتف خلال الربعيين القادمين
1 و2 والله اعلم

-------

الخسارة الصافيه تقريبا متقاربه للسنتين لكن 2004 اقل 700 الف تقريبا
Our net loss for the years ended December 31, 2004 was $24.0 million compared with $24.7 million for the year ended December 31, 2003, a decrease of $704,000. Of these losses, approximately $19.5 million and $8.6 million during 2004 and 2003, respectively, related to non-cash charges described herein and as follows and included only those items that would not have been required to be settled in cash or other assets by their original terms.




اتمنى تراجعون على التقرير السنوي
لان الشركة زمان عملت تقرير لتسع شهور
والان الصورة كامله سنوي
والارقام تخربط لهذا راجعوا بنفسكم

والله اعلم

الخوف موجود ولكن الامل موجود
ان شاء الله
 

m&m

عضو محترف
التسجيل
27 أغسطس 2002
المشاركات
2,086
الإقامة
السعوديه
السهم مرتفع 6% اخر جلسه

والسوق دمار
Nasdaq 1,908
؟؟

اخر رد لي لاني لن اتابعه
وتوقعاتي حسب وجهة نظري
ان السهم يمسي في قناة اعلاها كاهاي 17 سنت واللة 11 سنت
وقناة مستقبليه ان شاء الله يدخلها قريبا كاهاي 27 سنت واللو 17 سنت
ثم 52 سنت كامقامومة بعد ان كانت دعم
اتمنى تتحقق
وشكرا للجميع
 

الملفات المرفقه:

  • vtlvd15.jpg
    vtlvd15.jpg
    الحجم: 31.9 KB   المشاهدات: 216

abooyaser

عضو محترف - مشرف القسم السعودي
التسجيل
24 مايو 2004
المشاركات
3,425
مزيد من التحليل لسهم المستقبل

VectorVest Stock Analysis of Vital Living as of 4/27/2005


Thank you for requesting an analysis of Vital Living from VectorVest. The ticker symbol for Vital Living is VTLV. VTLV is traded on the Bulletin Board - (B)

Analysis Summary
VTLV is undervalued compared to its Price of $0.09 per share, has about average safety, and is currently rated a Sell.

In-Depth Analysis
Business: VITAL LIVING INC, (VTLV) Develops and markets nutraceuticals formulated by physicians for distribution through physicians. The company is developing and testing nutraceuticals in collaboration with medical experts based on the best available scientific evidence.

Price: VTLV closed on 4/27/2005 at $0.09 per share

Value: Value is a measure of a stock's current worth. VTLV has a current Value of $0.15 per share. Therefore, it is undervalued compared to its Price of $0.09 per share. Value is computed from forecasted earnings per share, forecasted earnings growth, profitability, interest, and inflation rates. Value increases when earnings, earnings growth rate and profitability increase, and when interest and inflation rates decrease. VectorVest advocates the purchase of undervalued stocks. At some point in time, a stock's Price and Value always will converge.

RV (Relative Value): RV is an indicator of long-term price appreciation potential. VTLV has an RV of 1.57, which is excellent on a scale of 0.00 to 2.00. This indicator is far superior to a simple comparison of Price and Value because it is computed from an analysis of projected price appreciation three years out, AAA Corporate Bond Rates, and risk. RV solves the riddle of whether it is preferable to buy High growth, High P/E stocks, or Low growth, Low P/E stocks. VectorVest favors the purchase of stocks with RV ratings above 1.00.

RS (Relative Safety): RS is an indicator of risk. VTLV has an RS rating of 0.90, which is fair on a scale of 0.00 to 2.00. RS is computed from an analysis of the consistency and predictability of a company's financial performance, debt to equity ratio, sales volume, business longevity, price volatility and other factors. A stock with an RS rating greater than 1.00 is safer and more predictable than the average stock in the VectorVest database. VectorVest favors the purchase of stocks of companies with consistent, predictable financial performance.

RT (Relative Timing): RT is a fast, smart, accurate indicator of a stock's price trend. VTLV has a Relative Timing rating of 0.52, which is poor on a scale of 0.00 to 2.00. RT is computed from an analysis of the direction, magnitude, and dynamics of a stock's price movements over one day, one week, one quarter and one year time periods. Once a stock's price has established a strong trend, it is expected to continue in that trend for the short-term. If a trend dissipates, RT will gravitate toward 1.00. RT will explode from bottoms, dive from tops, and reflect changes in price momentum. VectorVest favors the purchase of stocks with RT ratings above 1.00.

VST (VST-Vector): VST is the master indicator for ranking every stock in the VectorVest database. VTLV has a VST rating of 1.04, which is fair on a scale of 0.00 to 2.00. VST is computed from the square root of a weighted sum of the squares of RV, RS, and RT. Stocks with the highest VST ratings have the best combinations of Value, Safety and Timing. These are the stocks to own for above average, long-term capital appreciation. VectorVest advocates the purchase of safe, undervalued stocks rising in price.

CI (Comfort Index): CI is an indicator which reflects a stock's ability to resist severe and/or lengthy price declines. VTLV has a CI rating of 0.00, which is very poor on a scale of 0.00 to 2.00. CI is quite different from RS in that it is based solely upon a stock's long-term price history. VectorVest advocates the purchase of high CI stocks.

GRT (Earnings Growth Rate): GRT reflects a company's one to three year forecasted earnings growth rate in percent per year. VTLV has a forecasted Earnings Growth Rate of 37.00%, which VectorVest considers to be excellent. GRT is computed from historical, current and forecasted earnings data. It is updated each week for every stock in the VectorVest database. GRT often foretells a stock's future price trend. If a stock's GRT trend is upward, the stock's price will likely rise. If GRT is trending downward, the stock's Price will probably fall. VectorVest favors the purchase of stocks whose GRT is rising and is greater than the sum of current inflation and interest rates, (8.59%).

Recommendation (REC): VectorVest gives a Buy, Sell, Hold recommendation on every stock, every day. VTLV has a Sell recommendation. REC reflects the cumulative effect of all the VectorVest parameters working together. These parameters are designed to help investors buy safe, undervalued stocks rising in price. They also help investors avoid or sell risky, overvalued stocks falling in price. VectorVest recommends that investors buy high VST-Vector, Buy-rated stocks in rising markets.

Stop (Stop-Price): Stop is an indicator of when to sell a long position or cover a short position. VTLV has a Stop of $0.10 per share. This is $0.01 above VTLV's current closing Price. A stock's Stop is computed from a 13 week moving average of its closing prices, and is fine-tuned according to the stock's fundamentals. High RV, high RS stocks have lower Stops, and low RV, low RS stocks have higher Stops. In the VectorVest system, a stock gets a 'B' or 'H' recommendation if its Price is above its Stop and an 'S' recommendation if its Price is below its Stop.

يتبع
 

abooyaser

عضو محترف - مشرف القسم السعودي
التسجيل
24 مايو 2004
المشاركات
3,425
نهاية التحليل

EPS (Earnings per Share): EPS stands for leading 12 months Earnings Per Share. VTLV has a forecasted EPS of $-0.09 per share. VectorVest determines this forecast from a combination of recent earnings performance and traditional fiscal and/or calendar year earnings forecasts.

P/E (Price to Earnings Ratio): P/E is a popular measure of stock valuation which shows the dollars required to buy one dollar of earnings. VTLV has a P/E of -1.00. This ratio may be deemed to be high or low depending upon your frame of reference. The average P/E of all the stocks in the VectorVest database is 28.73. P/E is computed daily using the formula: P/E = Price/EPS.

EY (Earnings Yield): EY reflects earnings per share as a percent of Price. EY is related to P/E via the formula, EY = 100 / (P/E), and may be used in place of P/E as a measure of valuation. EY has the advantages that it is always determinate and can reflect negative earnings. VTLV has an EY of -99.00 percent. This is below the current average of 3.50% for all the stocks in the VectorVest database. EY equals 100 x (EPS/Price).

GPE (Growth to P/E Ratio): GPE is another popular measure of stock valuation. It compares earnings growth rate to P/E ratio. VTLV has a GPE rating of -36.63. High growth stocks are believed to be able to justify high P/E ratios. A stock is commonly considered to be undervalued when GPE is greater than 1.00 and overvalued when GPE is below 1.00. Unfortunately, this rule of thumb does not take into account the effect of interest rates on P/E ratios. The operative GPE ratio of 1.00 is valid when and only when interest rates equal 10%. With long-term interest rates currently at 5.49%, the operative GPE ratio is 0.30. Therefore, VTLV may be considered to be overvalued.

DIV (Dividend): VectorVest reports annual, regular, cash dividends as indicated by the most recent payments. Special distributions, one-time payments, stock dividends, etc., are not generally included in DIV. VTLV does not pay a dividend.

DY (Dividend Yield): DY reflects earnings per share as a percent of Price. VTLV does not pay a dividend, so it does not have a Dividend Yield rating. . DY equals 100 x (DIV/Price). It is useful to compare DY with EY. If DY is not significantly lower than EY, the dividend payment may be in jeopardy.

DS (Dividend Safety): DS is an indicator of the assurance that regular cash dividends will be declared and paid at current or at higher rates for the foreseeable future. VTLV does not pay a dividend, so it does not have a Dividend Safety rating . Stocks with DS values above 75 typically have RS values well above 1.00 and EY levels that are much higher than DY.


DG (Dividend Growth Rate): Dividend Growth is a subtle yet important indicator of a company's financial performance. It also provides some insight into the board's outlook on the company's ability to increase earnings. VTLV does not pay a dividend, so it does not have a Dividend Growth rating .

YSG (YSG-Vector): YSG is an indicator which combines DIV, DY and DG into a single value, and allows direct comparison of all dividend-paying stocks in the database. VTLV does not pay a dividend, so it does not have a YSG rating . Stocks with the highest YSG values have the best combinations of Dividend Yield, Safety and Growth. These are the stocks to buy for above average current income and long-term growth.

Open: VTLV opened trading at a price of $0.10 per share on 4/27/2005.

High: VTLV traded at a High price of $0.11 per share on 4/27/2005.

Low: VTLV traded at a Low price of $0.09 per share on 4/27/2005

Close: VTLV closed trading at price $0.09 per share on 4/27/2005. (Close is also called Price in the VectorVest system)

Range: Range reflects the difference between the High and Low prices for the day. VTLV traded with a range of $0.02 per share on 4/27/2005.

$Change: VTLV closed unchanged from the prior day's closing Price.

%PRC: VTLV's Price changed 0.00% from the prior day's closing price.

Volume: VTLV traded 114,900 shares on 4/27/2005.

AvgVol: AvgVol is the 50 day moving average of daily volume as computed by VectorVest. VTLV has an AvgVol of 101,800 shares traded per day.

%Vol: %Vol reflects the percent change in today's trading volume as compared to the AvgVol. %Vol equals ((Volume - AvgVol) / AvgVol ) * 100. VTLV had a %Vol of 12.87% on 4/27/2005

Sales: VTLV has annual sales of $3,000,000

Sales Growth: Sales Growth is the Sales Growth Rate in percent over the last 12 months. VTLV has a Sales Growth of 842.00% per year. This is excellent. Sales Growth is updated each week for every stock. It is often useful to compare Sales Growth to Earnings Growth to gain an insight into a company's operations.

Sales Per Share (SPS): VTLV has annual sales of $0.05 per share. SPS can be used as a measure of valuation when comparing stocks within an Industry Group.

Price to Sales Ratio (P/S): VTLV has a P/S of 1.76. This ratio is also used as a measure of valuation. Here, too, it is useful when comparing stocks within an Industry Group.

Shares: VTLV has 75,000,000 shares of stock outstanding.

Market Capitalization: VTLV has a Market Capitalization of $6,000,000. Market Capitalization is calculated by multiplying price times shares outstanding.

Industry Group: VTLV has been assigned to the Drug (Biomedical\Genetic) Industry Group. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.

Business Sector: VTLV has been assigned to the Drug Business Sector. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.

The basic strategy of VectorVest is to buy Low risk, High reward stocks. We suggest that Prudent investors buy enough High Relative Value, High Relative Safety stocks to keep the overall RV and RS ratings of their portfolios above 1.00. As you do this, you'll find that your risk will go down and your investment performance will improve.
Graph

Vital Living


Drug (Biomedical\Genetic)
سلالالالالالالا :) :) :) لالالالالالالالام..........
 

m&m

عضو محترف
التسجيل
27 أغسطس 2002
المشاركات
2,086
الإقامة
السعوديه
أعلى